Choate Investment Advisors Charles River Laboratories International, Inc. Transaction History

Choate Investment Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $45,736 - $66,397	-278 Reduced 5.38%	4,889 $1.16 Million
Q3 2023 Oct 30, 2023	BUY	$194.44 - $217.61 $11,277 - $12,621	58 Added 1.14%	5,167 $1.01 Million
Q2 2023 Aug 01, 2023	SELL	$183.71 - $210.25 $498,037 - $569,987	-2,711 Reduced 34.67%	5,109 $1.07 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $230,267 - $311,904	1,200 Added 18.13%	7,820 $1.58 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $878,716 - $1.11 Million	4,458 Added 206.2%	6,620 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $116,031 - $159,343	636 Added 41.68%	2,162 $425,000
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $66,954 - $99,187	328 Added 27.38%	1,526 $327,000
Q1 2022 Apr 29, 2022	BUY	$255.51 - $362.11 $306,100 - $433,807	1,198 New	1,198 $340,000

691

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Choate Investment Advisors with notifications on news.